Gamuda Bhd (5398)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 23 Oct 2026
Key indicators
| Last close | MYR 4.850 |
|---|---|
| 52-week range | 3.700 – 5.500 |
| Return, 1 month / 3 months | +1.5% / +13.1% |
| Return, 1 year / 3 years | −1.6% / +127.5% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 28.1% |
| Worst drawdown (1 year) | -30.7% |
| Average daily value traded | 88.96M MYR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gamuda is a Malaysian engineering, construction and infrastructure group based in Selangor. It builds large civil works such as rail lines, highways, tunnels and water infrastructure, and it also develops property and holds concessions in transport and utilities. Its customers are mainly governments and public agencies, alongside private developers, and it works on projects in Malaysia and in overseas markets including Australia and the wider region.
On this site Gamuda Bhd appears as a stock on the Kuala Lumpur Exchange (Malaysia), code 5398, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gamuda Bhd (5398) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 4.850 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 112 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.6% and over the last three months it rose 13.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.7% | ||
| From 52-week high | -11.0% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.1% | ||
| 6-month return | 10.0% | ||
| 12-month return, skipping the last month | -3.1% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.7% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 88.96M MYR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +1.5% |
| 3 months | +13.1% |
| 6 months | +10.0% |
| 1 year | −1.6% |
| 3 years | +127.5% |
| 5 years | +286.7% |
Signals
| 50-day / 200-day average | 4.757 / 4.381 |
|---|---|
| Golden / death cross (60 days) | Golden, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.122 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Aug 2026 | MYR 0.0500 |
| 4 Feb 2026 | MYR 0.0500 |
| 12 Aug 2025 | MYR 0.0500 |
| 7 Feb 2025 | MYR 0.0500 |
| 8 Aug 2024 | MYR 0.1000 |
| 30 Jan 2024 | MYR 0.0600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.